Original language | English |
---|---|
Pages (from-to) | 247-256 |
Journal | Lancet neurology |
Volume | 13 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2014 |
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
C. Confavreux, P. O'Connor, G. Comi, M.S. Freedman, A.E. Miller, T.P. Olsson, J.S. Wolinsky, T. Bagulho, J.L. Delhay, D. Dukovic, F. Barkhof, P. Truffinet, L. Kappos
Research output: Contribution to journal › Article › Academic › peer-review
442
Citations
(Scopus)